We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Risk Factors for Aneurysm Rebleeding

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01567449
Recruitment Status : Unknown
Verified March 2012 by Qingsong Lin, Fujian Medical University.
Recruitment status was:  Recruiting
First Posted : March 30, 2012
Last Update Posted : March 30, 2012
Information provided by (Responsible Party):
Qingsong Lin, Fujian Medical University

Brief Summary:
The purpose of this study is to examine the risk factors for aneurysm rebleeding.

Condition or disease
Subarachnoid Hemorrhage, Aneurysmal

Detailed Description:
To investigate risk factors for spontaneous aneurysm rebleeding during hospitalization and to reach conclusions if any,of clinical signs for predicting rebleeding.

Study Type : Observational
Estimated Enrollment : 66 participants
Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Risk Factors in Predicting Spontaneous Intracranial Aneurysm Rebleeding During Hospitalization
Study Start Date : September 2011
Primary Completion Date : March 2012
Estimated Study Completion Date : April 2012

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Aneurysms
U.S. FDA Resources

the case group
The case group referred to SAH patients with aneurysm rebleeding
the control group
the control group referred to SAH patients not with aneurysm rebleeding

Primary Outcome Measures :
  1. Aneurysm rebleeding [ Time Frame: up to 7 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
A total of 66 SAH patients were enrolled in this study

Inclusion Criteria:

  • Individual whose clinical course was clear enough to be traced back and whose conservative treatment duration was shorter than 6 weeks was included

Exclusion Criteria:

  • Rebleeding patients with certain inducing factors such as:

    • severe emotional episode,
    • severe coughing,
    • constipation,
    • excessive activities, or
    • with coagulation disorder,or
    • with other intracranial vascular malformations,such as:

      • moyamoya disease,
      • arteriovenous malformation were excluded.
  • Also patients who rebled while angiography were excluded.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01567449

Contact: qingsong lin, master 13489991226 lqs1210305061@163.com

China, Fujian
First Affiliated Hospital,Fujian Medical University Recruiting
Fuzhou, Fujian, China, 350005
Contact: Dezhi kang, professor    13859099988    kdz99988@sina.com   
Sponsors and Collaborators
Fujian Medical University
Study Director: Dezhi kang, professor First Affiliated Hospital of Fujian Medical University

Responsible Party: Qingsong Lin, Junior Doctor of Neurosurgery,Principal Investigator,Clinical Doctor, Fujian Medical University
ClinicalTrials.gov Identifier: NCT01567449     History of Changes
Other Study ID Numbers: 110011
First Posted: March 30, 2012    Key Record Dates
Last Update Posted: March 30, 2012
Last Verified: March 2012

Additional relevant MeSH terms:
Subarachnoid Hemorrhage
Pathologic Processes
Vascular Diseases
Cardiovascular Diseases
Intracranial Hemorrhages
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases